Merck KGaA MKKGY
33.67 USD -0.39 (-1.15%)
Nov 5, 2026, 12:57 PM EST
33.62 Day range 33.81
23.73 52-week range 34.19
- YTD
- +17.40%
- 1 year
- +32.56%
News
benzinga.com Why Is Silence Therapeutics Stock Skyrocketing Monday? Silence Therapeutics (SLN) leaps 126% on a $1.3B cash acquisition by Merck KGaA at $20 per ADS. Deal expected to close Q1 2027.
wsj.com Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target's closing price as of Friday.
defenseworld.net Merck KGaA (OTCMKTS:MKKGY) versus MediciNova (NASDAQ:MNOV) Head-To-Head Contrast Merck KGaA (OTCMKTS:MKKGY - Get Free Report) and MediciNova (NASDAQ: MNOV - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies…
defenseworld.net Merck KGaA (OTCMKTS:MKKGY) Shares Shorted: Short Interest Up 95.4% in September Merck KGaA (OTCMKTS:MKKGY - Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totaling 3,461 shares, an increase of…
defenseworld.net Merck KGaA (OTCMKTS:MKKGY) Receives Consensus Rating of “Hold” from Brokerages Shares of Merck KGaA (OTCMKTS:MKKGY - Get Free Report) have been given an average recommendation of "Hold" by the six analysts that are currently covering the stock, MarketBeat.com reports. Six…
benzinga.com Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
seekingalpha.com Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript
zacks.com Merck KGaA (MKKGY) Misses Q2 Earnings Estimates Merck KGaA (MKKGY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.57 per share a year ago.
businesswire.com Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development BAAR, Switzerland--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a new multi-year strategic collaboration to accelerate global clinical…
zacks.com Merck KGaA (MKKGY) Moves to Strong Buy: Rationale Behind the Upgrade Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
benzinga.com Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.
zacks.com Are Investors Undervaluing Merck KGaA (MKKGY) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
zacks.com Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock? Merck KGaA (MKKGY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
benzinga.com Bio-Techne To Pay Termination Fee Of $230.5M To Merck KGaA In Event That Deal Isn't Consummated; Merck KGaA To Pay Fee Of $576.1M If Deal Terminated Termination Fees The Company will be required to pay to Parent a termination fee equal to $230,455,000 (the "Company Termination Fee"): · If (A) the Merger Agreement is validly terminated (i) by…
benzinga.com Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial results, shares rose 17.1%; other big stocks also gained.
benzinga.com Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal Merck KGaA (OTC:MKKGY) (OTC:MKGAF) on Thursday agreed to acquire Bio-Techne Corporation (NASDAQ:TECH) in an all-cash transaction valued at approximately $11.3 billion, as the German science and…
benzinga.com Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
barrons.com Germany's Merck Is Buying Bio-Techne for $11.3 Billion Bio-Techne stock jumps, with Germany's Merck KGaA buying the company at a 24% premium.
benzinga.com CORRECTION: Germany's Merck KGaA To Acquire Bio-Techne At $73 Per Share In Cash At EV $11.3B; Deal Expected To Be Immediately Sales Accretive And EBITDA Pre Margin Post-Closing And EPS Pre Accretive By Year 3 Post-Closing Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation (NASDAQ:TECH), a Minneapolis-based global provider of life science tools, analytical technologies,…
reuters.com Germany's Merck to buy Bio-Techne for $73 per share Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
wsj.com Germany's Merck to Buy Bio-Techne for $11 Billion Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier's closing price Wednesday.
zacks.com Are Investors Undervaluing Merck KGaA (MKKGY) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
zacks.com Should Value Investors Buy Merck KGaA (MKKGY) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
seekingalpha.com Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript
marketbeat.com Merck KGaA Q1 Earnings Call Highlights Merck KGaA ETR: MRK reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised…
zacks.com Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates Merck KGaA (MKKGY) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.59 per share a year ago.
businesswire.com Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1…
benzinga.com Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…' Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.
benzinga.com Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges Inhibrx explores spin-off of INBRX-106 amid Big Pharma interest, with potential valuation exceeding $9 billion pending trial outcomes.
benzinga.com 'Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say' - Reuters https://www.reuters.com/world/merck-rivals-eye-deal-inhibrx-experimental-cancer-drug-tied-keytruda-sources-say-2026-04-22/
benzinga.com WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%)- benzinga.com Stocks That Hit 52-Week Highs On Tuesday
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday
- benzinga.com Stocks That Hit 52-Week Highs On Friday
benzinga.com Stocks That Hit 52-Week Highs On Friday - benzinga.com Stocks That Hit 52-Week Highs On Thursday